Clinical Utility of Selinexor/Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma: A Review of Current Evidence and Patient Selection

Panagiotis Malandrakis,* Ioannis Ntanasis-Stathopoulos,* Maria Gavriatopoulou, Evangelos Terpos Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece*These authors contributed equally to this workCorrespondence: Evangelos TerposDepart...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Malandrakis P, Ntanasis-Stathopoulos I, Gavriatopoulou M, Terpos E
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove Medical Press 2020-07-01
Colección:OncoTargets and Therapy
Materias:
selinexor
exportin
selective inhibitor of nuclear export
relapsed/refractory
myeloma
Acceso en línea:https://www.dovepress.com/clinical-utility-of-selinexordexamethasone-in-patients-with-relapsed-o-peer-reviewed-article-OTT
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares